MIF and central nervous system neoplasm: Specifically, C36L1 binds to CD74 to inhibit MIF signaling, which promotes the anti-tumorigenic activity of dendritic cells, macrophages, and T lymphocytes while reducing the immunosuppressive activity of regulatory T cells and MDSCs in the TME.180 These findings have the potential to be translated to primary CNS tumors.